Skip to main content
Clinical Trials/CTRI/2009/091/001058
CTRI/2009/091/001058
Completed
Phase 4

A COMPARATIVE STUDY TO EVALUATE EFFICACY AND SAFETY BETWEEN GABAPENTIN, PREGABALIN AND DULOXETINE IN PATIENTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY

Research society for the study of diabetes in India RSSDI0 sites152 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Peripheral diabetic neuropathy
Sponsor
Research society for the study of diabetes in India RSSDI
Enrollment
152
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Research society for the study of diabetes in India RSSDI

Eligibility Criteria

Inclusion Criteria

  • Either gender with type 2 diabetes b/w 5\-10 yrs duration
  • Patients with distal polyneuropathy by history, examination, biothesiometry \& Michigan Neuropathy Screening Instrument (MNSI)
  • Diabetic neuropathy (DN) for at least 3 months
  • Patients above 18 and below 65 years
  • HbA1C \< 10
  • Minimum VAS score for pain of 40 mm
  • Patients with written informed consent

Exclusion Criteria

  • Contraindications for the use of study drugs.
  • Hepatic, cardiac or renal failure
  • Patients with neuropathy due to other causes.
  • Patients who have undergone amputations of even one lower limb.
  • Pregnant and lactating women.

Outcomes

Primary Outcomes

Not specified

Similar Trials